BeiGene Ltd (BGNE)
173.14
+2.11
(+1.23%)
USD |
NASDAQ |
May 17, 16:00
173.14
0.00 (0.00%)
After-Hours: 20:00
BeiGene Price to Book Value: 5.377 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 5.377 |
| May 16, 2024 | 5.321 |
| May 15, 2024 | 5.129 |
| May 14, 2024 | 5.001 |
| May 13, 2024 | 5.045 |
| May 10, 2024 | 5.013 |
| May 09, 2024 | 5.246 |
| May 08, 2024 | 5.116 |
| May 07, 2024 | 4.995 |
| May 06, 2024 | 5.055 |
| May 03, 2024 | 5.048 |
| May 02, 2024 | 5.04 |
| May 01, 2024 | 4.870 |
| April 30, 2024 | 4.789 |
| April 29, 2024 | 4.869 |
| April 26, 2024 | 4.780 |
| April 25, 2024 | 4.623 |
| April 24, 2024 | 4.485 |
| April 23, 2024 | 4.326 |
| April 22, 2024 | 4.075 |
| April 19, 2024 | 4.031 |
| April 18, 2024 | 4.103 |
| April 17, 2024 | 4.100 |
| April 16, 2024 | 4.168 |
| April 15, 2024 | 4.304 |
| Date | Value |
|---|---|
| April 12, 2024 | 4.394 |
| April 11, 2024 | 4.544 |
| April 10, 2024 | 4.657 |
| April 09, 2024 | 4.789 |
| April 08, 2024 | 4.656 |
| April 05, 2024 | 4.665 |
| April 04, 2024 | 4.651 |
| April 03, 2024 | 4.725 |
| April 02, 2024 | 4.765 |
| April 01, 2024 | 4.951 |
| March 31, 2024 | |
| March 28, 2024 | 4.617 |
| March 27, 2024 | 4.578 |
| March 26, 2024 | 4.541 |
| March 25, 2024 | 4.544 |
| March 22, 2024 | 4.488 |
| March 21, 2024 | 4.833 |
| March 20, 2024 | 5.008 |
| March 19, 2024 | 4.963 |
| March 18, 2024 | 4.974 |
| March 15, 2024 | 5.019 |
| March 14, 2024 | 4.986 |
| March 13, 2024 | 5.210 |
| March 12, 2024 | 4.834 |
| March 11, 2024 | 4.854 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.123
Minimum
May 11 2022
13.96
Maximum
Feb 19 2020
6.179
Average
5.509
Median
Aug 11 2023
Price to Book Value Benchmarks
| Theravance Biopharma Inc | 2.205 |
| LumiraDx Ltd | -- |
| Dr Reddy's Laboratories Ltd | 3.355 |
| ASLAN Pharmaceuticals Ltd | -- |
| Jazz Pharmaceuticals PLC | 1.859 |
Price to Book Value Related Metrics
| PS Ratio | 6.568 |
| Price | 173.14 |
| Earnings Yield | -4.44% |
| Market Cap | 18.07B |